Tivozanib Terminated Phase 2 Trials for Hepatocellular Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01807156Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer